![]() |
市場調査レポート
商品コード
1486833
左心耳閉鎖デバイスの世界市場:洞察、競合情勢、市場予測:2030年Left Atrial Appendage Closure Devices - Market Insights, Competitive Landscape and Market Forecast-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
左心耳閉鎖デバイスの世界市場:洞察、競合情勢、市場予測:2030年 |
出版日: 2024年05月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2~10営業日
|
世界の左心耳閉鎖デバイスの市場規模は、2023年に12億694万米ドルとなりました。同市場は、2024年から2030年までの予測期間中に11.45%のCAGRで成長し、2030年までに25億6,470万米ドルに達すると予測されています。左心耳閉鎖デバイスの需要は、主に心房細動、虚血性脳卒中、心臓発作などの心血管障害の有病率の上昇によって強化されています。さらに、左心耳閉鎖デバイスの領域における技術進歩の増加は、2024年から2030年までの予測期間中に左心耳閉鎖デバイス市場の成長に寄与しているもう1つの重要な要因です。
American Heart Association 2020が提供したデータによると、欧州では2010年に55歳以上の900万人以上が心房細動を患っており、2060年までに1,400万人に達すると推定されています。さらに、同じ情報源によれば、2050年までにアジアでは心房細動とそれに関連する脳卒中が約7,200万件発生するとされています。このように、高カロリー食、喫煙、運動不足を含む様々な要因による心房細動のような心血管障害の有病率の上昇は、心血管障害の管理と治療の必要性を生み出し、左心耳閉鎖デバイス市場の前向きな成長をもたらします。
世界保健機関(WHO)が2021年に提供したデータによると、60歳以上の高齢者の割合は2015年から2050年の間に世界全体で12%から22%に倍増すると予想されています。この増加により、2050年には60歳以上の高齢者が合計21億人に達することになります。さらに2030年には、6人に1人が60歳以上の高齢者となります。年齢が上がるにつれて、心臓は正常な老化プロセスの一部として様々な構造的・機能的変化を受ける。これらの変化は心血管系に影響を及ぼし、様々な心血管系障害の持続や発症の一因となる可能性があります。したがって、老人人口の増加は左心耳閉鎖デバイス市場の成長にプラスの影響を与えると思われます。
当レポートでは、世界の左心耳閉鎖デバイス市場について調査し、市場の概要とともに、製品別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。
Left Atrial Appendage Closure Device Market By Product (Endocardial And Epicardial), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and geography is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of cardiovascular disorders and increasing technological advancements in the domain of left atrial appendage closure devices
The Global Left Atrial Appendage Closure Device Market Was Valued At USD 1,206.94 Million In 2023, Growing At A Cagr Of 11.45% during the forecast period from 2024 to 2030 to reach usd 2,564.70 million by 2030. The demand for left atrial appendage closure devices is primarily being bolstered by the rising prevalence of cardiovascular disorders such as atrial fibrillation, ischemic strokes, and heart attacks. additionally, increasing technological advancement in the domain of left atrial appendage closure, is another key factor that is contributing to the growth of the left atrial appendage closure market during the forecast period from 2024-2030.
Left Atrial Appendage Closure Device Market Dynamics:
As per the data provided American Heart Association 2020, it was estimated that in Europe more than 9 million individuals, who were older than 55 years were suffering from atrial fibrillation in the year 2010, which is expected to reach 14 million by 2060. Additionally, the same source stated that by the year 2050, there will be about 72 million cases of atrial fibrillation and associated strokes in Asia. Thus the rising prevalence of cardiovascular disorders such as atrial fibrillation due to various factors including high-calorie diet, smoking, and lack of physical inactivity, will create a need for the management and treatment of cardiovascular disorders, thus resulting in the positive growth of the left atrial appendage closure device market.
According to data provided by the World Health Organization in 2021, the percentage of people aged 60 years and above is expected to double from 12% to 22% between 2015 and 2050, globally. This increase will eventually lead to a total of 2.1 billion people aged 60 years or above by the year 2050. Additionally, by the year 2030, 1 in 6 people will be aged 60 years or above. As the age increases the heart undergoes various structural and functional changes as a part of the normal aging process. These changes can affect the cardiovascular system, potentially contributing to the persistence or development of various cardiovascular disorders. Therefore, the rise in the geriatric population will positively influence the growth of the left atrial appendage closure device market.
However, the high cost associated with the left atrial appendage closure devices and the presence of alternate treatment methods in the market, are some of the key constraints that may limit the growth of the left atrial appendage closure device market.
Left Atrial Appendage Closure Device Market Segment Analysis:
Left Atrial Appendage Closure Device market by Product (Endocardial and Epicardial), End-user (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product segment of the left atrial appendage closure device market, the endocardial category is estimated to amass a significant revenue share in the left atrial appendage closure device market in 2023. As technology is evolving, endocardial devices are becoming more sophisticated, offering improved efficacy and safety profiles compared to other devices. Additionally, endocardial LAA devices offers benefits such as reduced invasiveness, shorter recovery times, and fewer complications compared to the alternative methods. Further, Endocardial LAA devices, when compared with other products are very effective in managing stroke and reducing bleeding.
Thus, the various advantages provided by the endocardial LAA devices, will tend to increase the demand of the segment and in turn propelling the growth of the left atrial appendage closure devices during the forecast period.
North America Is Expected To Dominate The Overall Left Atrial Appendage Closure Device Market:
North America is expected to account for the highest proportion of the Left Atrial Appendage Closure Device Market in 2023, out of all regions. This is due to the high prevalence of cardiovascular disorders in the region. Additionally, rising technological advancements in the domain of left atrial appendage closure devices, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the left atrial appendage closure device market in North America.
As per the data provided American Heart Association 2020, it was estimated that at least 3 to 6 million people are suffering from atrial fibrillation and which is expected to reach 6 to 16 million by the year 2050 in the United States. Additionally, according to the data provided by the Centers for Disease Control and Prevention 2023, it was estimated that around 60 million women (44%), were living with some form of heart disease every year on average in the United States. Thus, with the rising prevalence of various cardiovascular disorders fueled by various factors such as sedentary lifestyle, consumption of alcohol and tobacco, and obesity, will create a need for the management and treatment of these diseases, thus eventually contributing to the positive growth of the left atrial appendage closure device market in the United States, which will eventually propel the left atrial appendage closure device market in North America.
Further, various key product launches and product approvals in the region are some of the other factors that are influencing the positive growth of the market in North America. For instance in August 2021, the Food and Drug Administration granted approval to Abbott for its Amplatzer Amulet Left Atrial Appendage Closure occluder, which is specially designed to treat individuals with atrial fibrillation who are at risk of ischemic stroke.
Therefore, the factors mentioned above, and the increasing product launches and product approvals in the region are some of the important factors that are thereby responsible for driving the overall market for Left Atrial Appendage Closure Devices in North America during the forecast period.
Left Atrial Appendage Closure Device Market Key Players:
Some of the key market players operating in the Left Atrial Appendage Closure Device market include Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Articure, Occlutech, Cardia Inc., Lifetech Scientific Corporation, Lepu Medical Technology, Biosense Webster, SentreHEART, Inc., Conformal Medical, and Lifetech Scientific Corporation
Recent Developmental Activities In The Left Atrial Appendage Closure Device Market:
Key Takeaways From The Left Atrial Appendage Closure Device Market Report Study
Target Audience Who Can Be Benefited From This Left Atrial Appendage Closure Device Market Report Study
Frequently Asked Questions For The Left Atrial Appendage Closure Device Market:
Left Atrial Appendage Closure (LAA) Devices are medical devices designed to reduce the risk of stroke in patients with atrial fibrillation (AF) who are at high risk of stroke and are unable to tolerate long-term anticoagulation therapy.
The global Left Atrial Appendage Closure Device Market was valued at USD 1,206.94 million in 2023, growing at a CAGR of 11.45% during the forecast period from 2024 to 2030 to reach USD 2,564.70 million by 2030.
The Left Atrial Appendage Closure Device market is slated to witness prosperity owing to factors such as the rising prevalence of cardiovascular disorders such as atrial fibrillation, ischemic strokes, and heart attacks. Additionally, increasing technological advancement in the domain of Left Atrial Appendage Closure, is another key factor which is contributing to the growth of the Left Atrial Appendage Closure market during the forecast period from 2024-2030.
Some of the key market players operating in the Left Atrial Appendage Closure Device market Boston Scientific Corporation, Johnson & Johnson, Abbott Laboratories, Articure, Occlutech, Cardia Inc., Lifetech Scientific Corporation, Lepu Medical Technology, Biosense Webster, SentreHEART, Inc., Conformal Medical and Lifetech Scientific Corporation.
North America is expected to dominate the overall Left Atrial Appendage Closure Device market during the forecast period, 2024 to 2030. This is due to the presence high prevalence of cardiovascular disorders in the region. Additionally, rising technological advancements, presence of major players in the region, and a highly viable market in terms of product development, and launches are some of the factors driving the growth of the Left Atrial Appendage Closure Device Market in North America.